Overview
This year about 20 insurers have announced capital-increase or bond plans. China Merchants Renhe Life received a fresh capital injection from China Merchants Group after a six-year gap; five insurance SOEs received RMB70bn from the Ministry of Finance’s RMB300bn special bond; Huatai Life’s RMB970m top-up was approved, HSBC Life raised twice within the year, and Luzhou Guotai Life’s two shareholders each plan RMB1bn. Perpetual bonds have become the main capital tool, with external “blood transfusion” intensifying.
Background & Interpretation
1. Regulatory and Industry Context
Amid a low-rate environment and mounting asset-liability matching pressure, business expansion and increased allocation to equity and other risk assets keep consuming solvency capital, making capital replenishment the industry’s annual theme. September’s RMB300bn special bond to replenish Tier-1 core capital for eight central financial institutions—for the first time including five insurance SOEs—signals clear financial-stability and risk-prevention intent.
2. Core Drivers and Underlying Mechanism
NFRA data show that by end-Q2 2026 the average comprehensive solvency ratio was 180.6% and core ratio 133.5%, down 23.9 and 14.3 percentage points year-on-year; life insurers’ comprehensive and core ratios were 169.7% and 119.6%. China Bond Rating notes that under C-ROSS II only future earnings from policies with remaining maturity ≥10 years count toward core capital and at no more than 35%, pressuring most insurers’ core capital—the underlying logic for external replenishment.
3. Market Structure and Value-Chain Impact
Large insurers are well-capitalized and replenish mainly pre-emptively; smaller insurers face the dual pressure of capital topping-up and business transformation. External financing (equity, perpetual bonds) addresses near-term needs, but over-reliance raises leverage and medium-term liquidity-management strain; improving efficiency and endogenous capital accumulation is the fundamental path. Analysts broadly view large insurers’ capital as ample, with top-ups reflecting forward-looking positioning.
Implications & Outlook
Capital constraints will force insurers to optimize business structure and control risk-asset exposure; equity allocation space is linked to solvency, affecting long-term capital’s market entry pace. The 2026 replenishment wave is expected to continue but turn more rational, with regulators refining capital instruments and market-exit mechanisms.
Takeaways for Industry Participants
- Insurers should balance external replenishment with endogenous accumulation and duration matching;
- Investors can track solvency and capitalization progress as allocation references;
- Regulators should refine capital-instrument supply and market-exit mechanisms to hold the risk line.
This column compiles industry information and shares technical perspectives; it does not constitute investment advice.